{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:42:39Z","timestamp":1773153759697,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T00:00:00Z","timestamp":1312675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00296-011-2017-5","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T04:34:46Z","timestamp":1312605286000},"page":"2769-2775","source":"Crossref","is-referenced-by-count":22,"title":["Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Christiane Aguiar","family":"Nobre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Roseli Monteiro","family":"Callado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Rubens Costa","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirla Wagner Poti","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germana Vasconcelos Mesquita","family":"Martiniano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walber Pinto","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,7]]},"reference":[{"key":"2017_CR1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"2017_CR2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"LP Ormerod","year":"2005","unstructured":"Ormerod LP, Milburn HJ, Gillespie S, Ledingham J, Rampton D (2005) BTS recommendations for assessing risk and managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNFa treatment. Thorax 60:800\u2013805","journal-title":"Thorax"},{"key":"2017_CR3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10067-008-0867-3","volume":"27","author":"I Hanta","year":"2008","unstructured":"Hanta I, Ozbek S, Kuleci S, Kocabas A (2008) The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients. Clin Rheumatol 27:1083\u20131086","journal-title":"Clin Rheumatol"},{"key":"2017_CR4","unstructured":"Minist\u00e9rio da Sa\u00fade (2010) Programa Nacional de Controle da Tuberculose\u2014Manual de Recomenda\u00e7\u00f5es para o Controle da Tuberculose no Brasil. http:\/\/portal.saude.gov.br\/portal\/arquivos\/pdf\/manual_de_recomendacoes_controle_tb_novo.pdf . Accessed 06 Oct 2010"},{"key":"2017_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein MR, Evans JG, Singh A et al (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-\u03b1 therapy. J Exp Med 200:277\u2013285","journal-title":"J Exp Med"},{"key":"2017_CR6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"D Ponce de Le\u00f3n","year":"2005","unstructured":"Ponce de Le\u00f3n D, Acevedo-V\u00e1squez E, S\u00e1nchez-Torres A et al (2005) Attenuated response to purified protein derivate in patients with rheumatoid arthritis: study in a population with high prevalence of tuberculosis. Ann Rheum Dis 64:1360\u20131361","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2017_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S1806-37132004000100001","volume":"30","author":"AC Filho","year":"2004","unstructured":"Filho AC, Kritski AL, Barreto AW et al (2004) II Consenso brasileiro de tuberculose. Diretrizes brasileiras para tuberculose. J Bras Pneumol 30(1):1\u201355","journal-title":"J Bras Pneumol"},{"issue":"2","key":"2017_CR8","first-page":"13","volume":"11","author":"MC Fa\u00e7anha","year":"2003","unstructured":"Fa\u00e7anha MC, Guerreiro MFF, Pinheiro AC et al (2003) Resgate de casos subnotificados de tuberculose em Fortaleza-CE, 2000\u20132002. Bol Pneumol Sanit 11(2):13\u201316","journal-title":"Bol Pneumol Sanit"},{"key":"2017_CR9","first-page":"706","volume":"34","author":"SS Seong","year":"2007","unstructured":"Seong SS, Choi CB, Woo JH et al (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis itself and tumor necrosis factor blocks. J Rhematol 34:706\u2013711","journal-title":"J Rhematol"},{"key":"2017_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S1806-37132004000700003","volume":"30","author":"JB Silva Jr","year":"2004","unstructured":"Silva JB Jr (2004) Tuberculose: Guia de Vigil\u00e2ncia Epidemiol\u00f3gica. J Bras Pneumol 30:57\u201385","journal-title":"J Bras Pneumol"},{"issue":"5","key":"2017_CR11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","volume":"57","author":"JJ Gomez-Reino","year":"2007","unstructured":"Gomez-Reino JJ, Carmona L, Descalzo A, BIOBADASER GROUP (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57(5):756\u2013761","journal-title":"Arthritis Rheum"},{"key":"2017_CR12","first-page":"221","volume":"161","author":"G Panayi","year":"2001","unstructured":"Panayi G, Corrigal V, Pitzalis C (2001) Pathogenesis of rheumatoid arthritis. The role of cells and others beasts. Rheum Dis Clin North Am 161:221\u2013247","journal-title":"Rheum Dis Clin North Am"},{"key":"2017_CR13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/38.12.1203","volume":"38","author":"VM Corrigal","year":"1999","unstructured":"Corrigal VM, Garyfallos A, Panayi GS (1999) The relative proportions of secreted interleukin-2 and interleukin-10 determine the magnitude of rheumatoid arthritis T-cell proliferations to the recall antigen tuberculin purified protein derivative. Rheumatology 38:1203\u20131207","journal-title":"Rheumatology"},{"key":"2017_CR14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/ard.43.3.430","volume":"43","author":"P Emery","year":"1984","unstructured":"Emery P, Panayi G, Symmons D, Brown G (1984) Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis 43:430\u2013434","journal-title":"Ann Rheum Dis"},{"key":"2017_CR15","first-page":"667","volume":"14","author":"GH Kingsley","year":"1987","unstructured":"Kingsley GH, Pitzalis C, Panay GS (1987) Abnormal lymphocyte reactivity to self-major histocompatibility antigens in rheumatoid arthritis. J Rheumatol 14:667\u2013673","journal-title":"J Rheumatol"},{"issue":"2","key":"2017_CR16","first-page":"121","volume":"49","author":"CDL Marques","year":"2009","unstructured":"Marques CDL, Duarte ALBP, Lorena VMB et al (2009) Resposta atenuada ao PPD no diagn\u00f3stico de infec\u00e7\u00e3o tuberculosa latente em pacientes com artrite reumat\u00f3ide. Rev Bras Reumatol 49(2):121\u2013131","journal-title":"Rev Bras Reumatol"},{"key":"2017_CR17","unstructured":"Laurindo IMM, Seiscento M, Bombardia S et al (2004) Diagnosis of latent tuberculosis in rheumatoid arthritis (RA) patients: tuberculin test (PPD) assessment. EULAR, Rheumatoid arthritis clinical aspects [THU0235]. http:\/\/www.abstracts2view.com\/eular\/sessionindex.php?session=2004374&day=2004 . Accessed 27 Jan 2010"},{"issue":"5","key":"2017_CR18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0074-02762005000500002","volume":"100","author":"TCB Andrade","year":"2005","unstructured":"Andrade TCB, Maia RM, Cosgrove C, Castelo Branco LRR (2005) BCG Moreau Rio de Janeiro\u2013An oral vaccine against tuberculosis\u2013review. Men Inst Oswaldo Cruz 100(5):459\u2013465","journal-title":"Men Inst Oswaldo Cruz"},{"issue":"6","key":"2017_CR19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0037-86822005000600004","volume":"38","author":"ELN Maciel","year":"2005","unstructured":"Maciel ELN, Viana MC, Zeitoune RCG, Ferreira I, Fregona G, Dietze R (2005) Prevalence and incidence of Mycobacterium tuberculosis infection in nursing students in Vit\u00f3ria, Esp\u00edrito Santo. Rev Soc Bras Med Trop 38(6):469\u2013472","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"2017_CR20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1590\/S0037-86822008000400019","volume":"41","author":"FH Pilsczek","year":"2008","unstructured":"Pilsczek FH, Kaufmann SHE (2008) Prevalence and predictors of positive tuberculin skin test results in a research laboratory. Rev Soc Bras Med Trop 41(4):416\u2013418","journal-title":"Rev Soc Bras Med Trop"},{"key":"2017_CR21","first-page":"54","volume":"25","author":"IH K\u00f6ker","year":"2007","unstructured":"K\u00f6ker IH, Pamuk \u00d6N, Karlikaya C, Tun\u00e7bilek N, \u00c7akir N (2007) A low prevalence of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings. Clin Exp Rheumatol 25:54\u201359","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2017_CR22","first-page":"84","volume":"50","author":"MM Pinheiro","year":"2010","unstructured":"Pinheiro MM, Melo MR, Jennings MF, Barbosa CP, Terreri MT, Hil\u00e1rio MOE (2010) Positividade do teste tubercul\u00ednico em crian\u00e7as e adultos com artropatias inflamat\u00f3rias cr\u00f4nicas e indica\u00e7\u00e3o para o uso de terapia anti-TNF. Congresso Brasileiro de Reumatologia 2010, Artrite reumat\u00f3ide\/epidemiologia e aspectos cl\u00ednicos. Rev Bras Reumatol 50(1):84","journal-title":"Rev Bras Reumatol"},{"key":"2017_CR23","doi-asserted-by":"crossref","unstructured":"Pereira SM, Dantas OMS, Ximenes R, Barreto ML (2007) Vacina BCG contra tuberculose: efeito protetor e pol\u00edticas de vacina\u00e7\u00e3o. Rev Sa\u00fade P\u00fablica 41(Supl. 1):59\u201366. http:\/\/www.scielosp.org\/pdf\/rsp\/v41s1\/6492.pdf . Accessed 08 Oct 2010","DOI":"10.1590\/S0034-89102007000800009"},{"issue":"7","key":"2017_CR24","first-page":"842","volume":"8","author":"M Saito","year":"2004","unstructured":"Saito M, Bautista CT, Gilman RH, Bowering A, Levy MZ, Evans CA (2004) The value of counting BCG scars for interpretation of tuberculin skin tests in a tuberculosis hyperendemic shantytown, Peru. Int J Tuberc Lung Dis 8(7):842\u2013847","journal-title":"Int J Tuberc Lung Dis"},{"key":"2017_CR25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/thx.2005.042457","volume":"60","author":"G Provenzano","year":"2005","unstructured":"Provenzano G, Ferrante MC, Simon G (2005) TB screening and anti-TNF \u03b1 treatment. Thorax 60:612\u2013615","journal-title":"Thorax"},{"key":"2017_CR26","doi-asserted-by":"crossref","unstructured":"Sellam J, Hamdi H, Roy C et al (2007) Comparison of in vitro-speciWc blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann Rheum Dis. doi: 10.1136\/ard.2007.069799","DOI":"10.1136\/ard.2007.069799"},{"issue":"3","key":"2017_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.mcp.0000158726.13159.5e","volume":"11","author":"K Dheda","year":"2005","unstructured":"Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA (2005) Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 11(3):195\u2013202","journal-title":"Curr Opin Pulm Med"},{"key":"2017_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00296-009-0910-y","volume":"30","author":"CDL Marques","year":"2009","unstructured":"Marques CDL, Duarte ALBP, Lorena VMB et al (2009) Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis. Rheumatol Int 30:57\u201362","journal-title":"Rheumatol Int"},{"key":"2017_CR29","unstructured":"Montoro M, Gonzalez C, L\u00f3pez-Longo FJ et al (2009) New PPD-positive test during infliximab treatment. ACR Annual meeting, Abstract 135. http:\/\/acr.confex.com\/acr\/2009\/webprogram\/paper15520.html . Accessed 26 Nov 2010"},{"key":"2017_CR30","unstructured":"Cush JJ, Winthrop K, Dao K et al (2010) ACR Safety Committee. Screening for Mycobacterium tuberculosis Infection: questions and answers for clinical practice. http:\/\/www.rheumatology.org\/publications\/dsq\/dsq_2010_02.pdf . Accessed 26 Nov 2010"},{"key":"2017_CR31","unstructured":"Cooray D, Moran R, Broumand A et al (2009) Serial re-screening in high risk patients on anti-TNF &alpha therapy validate CDC recommendations of monitoring TB risk. ACR annual meeting, Abstract 1153. http:\/\/acr.confex.com\/acr\/2009\/webprogram\/paper15478.html . Accessed 26 Nov 2010"},{"issue":"2","key":"2017_CR32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-008-1007-9","volume":"28","author":"I Fuchs","year":"2009","unstructured":"Fuchs I, Avnon L, Freud T, Abu-Shakra M (2009) Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin Rheumatol 28(2):167\u2013172","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2017-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2017-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2017-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T20:55:47Z","timestamp":1560459347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2017-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,7]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2017-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,7]]}}}